J, M., TH, C., CM, B., & SS, S. (2026). Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime. International journal of antimicrobial agents, 107897. https://doi.org/10.1016/j.ijantimicag.2026.107897
Chicago Style (17th ed.) CitationJ, Magagnoli, Cummings TH, Bland CM, and Sutton SS. "Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime." International Journal of Antimicrobial Agents 2026: 107897. https://doi.org/10.1016/j.ijantimicag.2026.107897.
MLA (9th ed.) CitationJ, Magagnoli, et al. "Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime." International Journal of Antimicrobial Agents, 2026, p. 107897, https://doi.org/10.1016/j.ijantimicag.2026.107897.